WavKong V2700 Takes a Signal-First Approach to Whole-Home Wi-Fi

Wider Coverage. Cleaner Signal. Fewer Nodes. Proprietary RPU⢠technology targets the hard-to-reach corners of large homes, with up to 15,000 sq. ft. of combined indoor-outdoor coverage in company testing.

NEW YORK, Oct. 30, 2026 /PRNewswire/ -- WavKong today announced the commercial launch of its V2700 long-range Wi-Fi 6 router following the successful fulfillment of all Kickstarter orders. Its approach to whole-home Wi-Fi is built on a simple principle: Improve the wireless signal at its source, then use the fewest nodes necessary to deliver reliable coverage across even the largest or most complex homes.

From the upstairs bedroom where a daughter streams and studies, to a garage, a backyard gathering, or a security camera on a barn, reliable Wi-Fi should reach the places people actually useânot just the room closest to the router.

Developed over six years, WavKong's proprietary RPU⢠(Radio Processing Unit) chip brings base-station-grade digital signal processing to home Wi-Fi. In company testing at a single-story, wood-frame residence in California, one V2700 provided up to 15,000 square feet of combined indoor-outdoor Wi-Fi coverage. WavKong has also tested the router in three-story wood-frame homes in other U.S. states.

The Problem Isn't Always the Internet Plan. It's the Last Stretch of Wi-Fi.

A household can pay for fast broadband and still lose usable speed at the edges of the property. A phone may show a Wi-Fi connection in the garden, yet a video call freezes. A camera on an outbuilding may connect intermittently. A bedroom two floors away may become a daily dead zone.

Mesh networking is an effective way to extend Wi-Fi coverage, especially in homes with challenging layouts. But the best network is not necessarily the one with the most nodes. Each additional wireless point requires thoughtful placement and coordination of radio channels, backhaul and roaming. For households that are not networking experts, getting that design right can be difficult.

WavKong focuses on strengthening the underlying wireless link so fewer nodes may be needed to deliver dependable coverage. In many suitable homes, one V2700 can be enough. Where building materials or layout call for more coverage, two properly positioned V2700 units can work together in a Mesh network to deliver high-speed whole-home Wi-Fi. The goal is not to eliminate Mesh; it is to make the network simpler by needing fewer nodes.

The Technology: Cleaner RF, Not Just More Power

The V2700's RPU⢠targets a fundamental radio-frequency challenge. As a Wi-Fi power amplifier operates at higher output levels, nonlinear distortion can compromise signal quality, limiting the speeds devices can sustain at longer range. Digital predistortion compensates for that distortion before transmission, helping preserve signal linearity.

Digital predistortion (DPD) algorithms have long been used in cellular base stations and satellite communications. WavKong has brought this class of digital RF processing into the 5 GHz radio path of a home Wi-Fi router through its dedicated RPU⢠chipâadding a digital processing core to the radio system to compensate for power-amplifier distortion. Its engineering team brings decades of experience in mobile-communications algorithms, RF systems, and communications-chip development.

In laboratory testing at 160 MHz channel bandwidth and 1024-QAM, DPD improved error vector magnitude (EVM) from approximately â29.3 dB to â41.2 dB, a gain of more than 12 dB. In everyday terms, cleaner RF transmission helps maintain usable speeds farther from the router. Small Chip. Giant Leap.

What the Testsâand Early UsersâShow

At a single-story, wood-frame California residence, WavKong tested indoor and outdoor coverage, including a distant garden location where the V2700 measured 123 Mbps, versus 4.2 Mbps for the comparison Mesh configuration. Separate testing in other U.S. states included three-story wood-frame houses, reflecting the different layouts and distances households need Wi-Fi to reach.

Independent real-world comparisons also show why network design matters. Technology creator Jeff Springer compared one V2700 with a well-known Mesh Wi-Fi brand: the V2700 delivered higher speeds than an individual Mesh node at several distant locations. Against the full three-node Mesh setup, the V2700 was faster at two of four test locations, while the Mesh system led at the other two. The point is not that Mesh is inferior; it is that stronger individual wireless links can reduce the number of nodes needed in suitable homes.

Other early users reported meaningful coverage gains. An Australian customer who had used a router plus two Mesh nodes reported 5 GHz downloads exceeding 500 Mbps after switching to V2700, versus about 250 Mbps previously. Another user reported that a previously unreliable smart doorbell became more stable after six weeks of use.

Coverage and speed figures reflect WavKong's internal tests or individual user reports under specific conditions. Actual results vary with walls and building materials, interference, router placement, client capabilities, and network configuration.

From Six Years of Engineering to Global Delivery

The V2700 launched on Kickstarter on April 22, 2026, earning "Project We Love" recognition within its first 24 hours. The campaign attracted 1,074 backers and raised HK$3,272,087 (more than US$400,000). WavKong completed Kickstarter fulfillment on September 29, following product validation, early-user testing, and the start of mass production.

"Great Wi-Fi should be invisible. People should enjoy reliable connectivity wherever life happensâupstairs, in the garage, out in the garden, or even at a security camera near the barnâwithout becoming networking experts," said Dr. Ziming Wang, CEO of WavKong. "Wireless performance starts with the quality of the signal, not the number of devices. That is why we went back to the fundamentals of RF engineering, bringing base-station-grade digital signal processing into home Wi-Fi. Our goal is simple: stronger signals, wider coverage, and fewer nodes where possible. Technology should make connectivity effortless, not more complicated."

The V2700 is available through WavKong's official website, with shipping to supported markets. It supports Wi-Fi 6, 160 MHz channel bandwidth, WPA3 security, and router or access-point deployment.

Product information: https://wavkong.com

About WavKong

WavKong is a consumer technology brand of Digital Enhancement, dedicated to bringing advanced wireless innovations into everyday life. By integrating proprietary Digital RF algorithms and custom-designed processor chips into consumer products, WavKong transforms sophisticated wireless technologies into practical, easy-to-use solutions that deliver stronger performance, wider coverage, and more reliable connectivity.

SOURCE WavKong

Share this article

- The Roosevelt New Orleans, A Waldorf Astoria Hotel, announced the opening of Café Alice, a new all-day dining concept that brings fresh energy and character to the storied property. Reimagining the former Teddy’s Café, the European-style café and bar features a menu from Executive Chef Daniel Mills and Pastry Chef Kareena Dennis, with coffee, house-made pastries, breakfast dishes, savory small plates and cocktails.

- Café Alice pays tribute to the legendary Alice Roosevelt, the first daughter of the hotel’s namesake, President Theodore Roosevelt, whose bold personality and unconventional spirit made her one of the most talked-about figures of her time. The café and bar channels that same sense of whimsy and individuality, with expressive design and an imaginative menu.

- Café Alice joins The Roosevelt New Orleans’ celebrated culinary portfolio, offering an all-day counterpoint to the relaunched Fountain Lounge, landmark Sazerac Bar, Italian-inspired Domenica, seasonal Rooftop Bar and 24-hour in-room dining. Café Alice is open daily from 6:00 a.m. to 8:00 p.m.

NEW ORLEANS – The historic grande dame of the French Quarter, The Roosevelt New Orleans, A Waldorf Astoria Hotel, today announced the opening of Café Alice, a new all-day dining concept that brings fresh energy and character to the storied property. Reimagining the former Teddy’s Café, the European-style café and bar features a menu from Executive Chef Daniel Mills and Pastry Chef Kareena Dennis. From coffee, house-made pastries and breakfast dishes to savory small plates and cocktails, Café Alice offers a creative range of options throughout the day.

Café Alice pays tribute to the legendary Alice Roosevelt, the first daughter of the hotel’s namesake, President Theodore Roosevelt, whose bold personality and unconventional spirit made her one of the most talked-about figures of her time. The café and bar channels that same sense of whimsy and individuality, with expressive design and an imaginative menu that feel unmistakably like The Roosevelt.

“Café Alice honors The Roosevelt’s storied legacy while creating a distinctive experience for today’s guests,” said Sebastian Stutz, general manager, The Roosevelt New Orleans, A Waldorf Astoria Hotel. “Through thoughtful storytelling, culinary creativity and a playful character all its own, it joins celebrated destinations such as the Sazerac Bar in offering guests and locals another memorable way to experience the hotel.”

The Menu

Executive Chef Daniel Mills has crafted a bespoke menu featuring inventive signature breakfast dishes and beverages alongside classic staples that celebrate the city’s culinary traditions. Guests will find dishes inspired by Alice Roosevelt and her colorful life, including Alice's Emily Spinach Benedict, a nod to the first daughter’s pet garter snake, Emily Spinach, and her menagerie of pets at the White House, as well as the Alice Blue Latte which honors the color she wore so often that it became the unofficial name for the shade. The latte utilizes spirulina to achieve the pale blue shade that became known as “Alice Blue,” along with coconut, vanilla, espresso, and coconut milk.

Lunch and dinner menus pair elevated ingredients with quintessential Southern flavors such as The Black Tie Chicken, featuring crispy chicken bites alongside shaved black truffle, caviar and crème fraiche. Guests can also enjoy a selection of cocktails such as The Wild Child withBombay Sapphire Gin and matcha; the Espresso Beignet with Altamura Vodka, Beignet Liqueur, Caffè Lucano and espresso; and Doctor’s Bellini with Juliette Heirloom Peach Liqueur and Peychaud’s Bitters.

Hand-crafted pastries by The Roosevelt’s Pastry Chef Kareena Dennis will be available day and night, showcasing unexpected ingredients and flavor pairings, including the Matcha-Yuzu Éclair, Sazerac Apple Tatin Entremet and Ube Basque Cheesecake.

“The menu is inspired by Alice’s out-of-the-box personality and the relaxed style of French brasseries while remaining true to our roots and providing guests with authentic Southern cuisine,” said Executive Chef Daniel Mills, The Roosevelt New Orleans, A Waldorf Astoria Hotel. “What our team has delivered captures that vision entirely, elevating the traditional all-day café. We're excited for guests to step into Alice’s world and discover it for themselves.”

The Design

Inspired by Alice Roosevelt’s spirited personality and unconventional style, the interiors by ForrestPerkins balance refined elegance with a playful sense of discovery. Climbing botanicals paper the walls, framing romantic architectural moldings and arched brass niches, while a green latticed ceiling brings an expressive note to the space. Warm cream and sun-washed terracotta tones soften the design, complemented by marble-topped tables and plush velvet banquettes that invite guests to linger. Together, these thoughtful details create a distinctive setting that captures the convivial spirit of New Orleans café culture while bringing the imaginative world of Café Alice to life.

To celebrate the launch and in recognition of Alice’s love of animals, Café Alice has partnered with the Audubon Nature Institute. For a limited time, guests who purchase the Critter Sable Cookie Sandwich, Café Alice’s twist on the classic animal cracker, will receive a discount on admission to the zoo. A portion of proceeds from the pastry will support the Audubon Nature Institute’s Marine Mammal Rescue program and its turtle release efforts.

Café Alice joins The Roosevelt New Orleans’ celebrated culinary portfolio, offering an all-day counterpoint to the relaunched Fountain Lounge, landmark Sazerac Bar, Italian-inspired Domenica, seasonal Rooftop Bar and 24-hour in-room dining. Together, these venues reflect Waldorf Astoria’s tradition of culinary excellence while providing guests with a range of dining options from morning through evening.

Café Alice was developed in collaboration with StiR Creative Collective, Hilton’s in-house global food and beverage consultancy arm, which worked alongside Executive Chef Daniel Mills and The Roosevelt team to shape the concept’s culinary direction, storytelling and guest journey. The collaboration builds on StiR’s work across Hilton’s luxury portfolio throughout the Americas, including Peacock Alley and Lex Yard at Waldorf Astoria New York, Leonessa at Conrad New York Downtown, Brassica at Waldorf Astoria Atlanta Buckhead, the culinary program at Conrad Orlando and more.

Café Alice is open daily from 6:00 a.m. to 8:00 p.m. Learn more at therooseveltneworleans.com.

Read more about Waldorf Astoria Hotels & Resorts at stories.hilton.com/waldorfastoria.

The Roosevelt New Orleans, A Waldorf Astoria Hotel, Opens Whimsical New All-Day Dining Concept, Café Alice

Café Alice is a new all-day dining concept at The Roosevelt New Orleans, A Waldorf Astoria Hotel, that brings fresh energy and character to the storied property. Reimagining the former Teddy’s Café, the European-style café and bar features a menu from Executive Chef Daniel Mills and Pastry Chef Kareena Dennis, with coffee, house-made pastries, breakfast dishes, savory small plates and cocktails.

Café Alice pays tribute to the legendary Alice Roosevelt, the first daughter of the hotel’s namesake, President Theodore Roosevelt, whose bold personality and unconventional spirit made her one of the most talked-about figures of her time.

Café Alice is located at The Roosevelt New Orleans, A Waldorf Astoria Hotel, just a few steps away from the French Quarter. The historic hotel has been open since 1893 and is a timeless and storied architectural marvel whose history is synonymous with that of New Orleans itself.

Café Alice is open daily from 6:00 a.m. to 8:00 p.m., offering guests a range of dining options throughout the day.

Executive Chef Daniel Mills has crafted a bespoke menu featuring inventive signature breakfast dishes and beverages alongside classic staples that celebrate the city’s culinary traditions. Lunch and dinner menus pair elevated ingredients with quintessential Southern flavors, while hand-crafted pastries by The Roosevelt’s Pastry Chef Kareena Dennis are available day and night, showcasing unexpected ingredients and flavor pairings.

Café Alice is inspired by Alice Roosevelt’s spirited personality and unconventional style. The café and bar channels that same sense of whimsy and individuality, with expressive design and an imaginative menu that feel unmistakably like The Roosevelt. The interiors by ForrestPerkins balance refined elegance with a playful sense of discovery.

Media Contact

About Hilton

Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 28 world-class brands comprising more than 9,600 properties and over 1.4 million rooms, in 144 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed over 4 billion guests in its more than 100-year history. Named as the No. 1 World’s Best Workplace by Great Place to Work and Fortune, Hilton aims to create the best culture for its 500,000 team members around the world. Hilton has introduced industry-leading technology enhancements to improve the guest experience, including Digital Key Share, automated complimentary room upgrades and the ability to book confirmed connecting rooms. Through the award-winning guest loyalty program Hilton Honors, the more than 270 million Hilton Honors members who book directly with Hilton can earn Points for hotel stays and experiences money can't buy. With the free Hilton Honors app, guests can book their stay, select their room, check in, unlock their door with a Digital Key and check out, all from their smartphone. Visit stories.hilton.com for more information, and connect with Hilton on Facebook, X, LinkedIn, Instagram and YouTube.

RESTON, Va., Oct. 30, 2026 /PRNewswire/ -- CACI International Inc (NYSE: CACI) today announced a milestone for its Good Dogs for Great Americans philanthropy program. Through this partnership with the Washington Capitals and America's VetDogs, CACI has delivered enough funding to support the raising, training, and placement of a specially trained service dog with a veteran.

Good Dogs for Great Americans turns defensive plays on the ice into meaningful support for those who have served our nation. Through the program, CACI donates $250 for every shot blocked by the Capitals, helping fund the extensive training and care required to prepare service dogs for veterans living with physical disabilities, post-traumatic stress, hearing and vision loss, and other challenges.

Midway into the first period of Thursday evening's match against the Nashville Predators, Washington Capitals defenseman Matt Roy recorded the season's 200th blocked shot, pushing CACI's donation total to $50,000 and officially funding the program's first veteran-service dog pairing. The Capitals' commitment to defense has powered the effort all season, led by defenseman Martin Fehérváry, whose team-leading 32 blocked shots have helped drive the program toward this achievement.

"When we launched Good Dogs for Great Americans, we knew every blocked shot could become something much bigger than a statistic," said Mike Shields, senior vice president at CACI and ambassador for Good Dogs for Great Americans. "Reaching this milestone means a future service dog is now beginning a journey that will ultimately lead to a veteran gaining a trusted partner, greater independence, and renewed confidence in daily life. Seeing that connection take shape is incredibly meaningful for everyone involved."

With this funding, America's VetDogs will immediately select a specialized service dog that is in the final stages of 18â24 months of preparation. The dog will be matched with a veteran, and both will complete a twoâweek intensive training program at the America's VetDogs campus in New York. The pair will graduate in December and begin their journey together as a new team for independence.

"Raising $50,000 to cover the cost of training and placing a service dog with a veteran is an incredible milestone, and we are deeply grateful to CACI and the Washington Capitals for making it possible," said John Miller, president and CEO of America's VetDogs. "Through the Good Dogs for Great Americans partnership, every blocked shot by the Caps has helped make a difference. This is a powerful example of how teamwork and generosity can create a lasting, life-changing impact for those who have served our country."

Thanks to the Capitals's relentless shot-blocking efforts, the $50,000 needed to fully fund a veteran-service dog team was raised in just under one month. Every Capitals blocked shot this NHL season continues to generate funding, helping place more service dogs with veterans who need them most.

America's VetDogs is a national nonprofit that places specially trained service dogs with veterans, first responders, and active-duty service members with disabilities. It costs more than $50,000 to raise, train and place one service dog, but there is never a charge to the individual.

Fans can follow the program's progress and learn more about the service dogs, veterans, and stories behind the initiative at CACIGoodDogs.com.

About CACI

CACI International Inc (NYSE: CACI) is a technology-first national security company that expands the limits of national security through innovation, discipline, and operational excellence. We deliver advanced technologies that help our customers move faster, operate more efficiently, and anticipate and defeat evolving threats. Our 27,000 talented employees and strong culture drive our success and have earned CACI recognition as a Fortune World's Most Admired Company. CACI is a member of the Fortune 500â¢, the Russell 1000 Index, and the S&P MidCap 400 Index. For more information, visit caci.com.

About Monumental Sports & Entertainment

Monumental Sports & Entertainment (MSE) is one of the leading integrated sports and entertainment companies globally. MSE's portfolio spans premier professional sports teams, world-class venues, and next-generation media properties, with marquee assets including the NHL's Washington Capitals, NBA's Washington Wizards, WNBA's Washington Mystics, NBA G League's Capital City Go-Go, Capital One Arena, and Monumental Sports Network, along with an investment in Team Liquid.

Rooted in the nation's capital, MSE brings Washington, D.C.'s distinct influence, ambition, and leadership to the global sports and entertainment landscape. The company harnesses the power of its platform to drive continuous innovation and deliver extraordinary experiences that inspire and unite our community, our fans, and our people. For additional information on MSE, please visit monumentalsports.com.

About America's VetDogs

For more than 20 years, America's VetDogs (www.VetDogs.org) has trained and placed guide and service dogs to provide independence, enhanced mobility, and companionship to veterans with disabilities from all eras. In 2015, America's VetDogs opened its programs to first responders, including fire, police, and emergency medical personnel. America's VetDogs is a 501(c)(3) not-for-profit organization founded by the Guide Dog Foundation (est. 1946) and serves our country's and communities' heroes in all 50 states, Washington, DC. Puerto Rico, and beyond. America's VetDogs relies on contributions from generous individuals, corporations, service clubs, and foundations to fund its mission to help those who have served our country live with dignity and independence. It costs more than $50,000 to breed, raise, train, and place one assistance dog, but America's VetDogs provides its services completely free of charge to the individual. America's VetDogs has been accredited by both the International Guide Dog Federation and Assistance Dogs International. Apply, volunteer, and donate at VetDogs.org.

SOURCE CACI International Inc

Share this article

Beyond Conventional Anti-TIGIT: HanchorBio Secures Taiwan TFDA Approval for HCB303 Following U.S. FDA Clearance

Differentiated trispecific TIGIT-Fc ligand-trap strategy aims to address CD226 downregulation, a potential limitation of conventional anti-TIGIT antibodies

U.S FDA clearance followed by accelerated Taiwan TFDA approval advances HCB303 toward multi-regional Phase 1 clinical development

TAIPEI, SHANGHAI and SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- HanchorBio, Inc. (TWSE: 7827), a global clinical-stage biotechnology company developing next-generation immunotherapies for oncology and immune-mediated diseases, today announced that its wholly owned subsidiary, FBD Biologics Limited, has received approval from the Taiwan Food and Drug Administration (TFDA) for the Investigational New Drug (IND) application for HCB303, a next-generation trispecific fusion protein featuring a differentiated TIGIT-Fc ligand-trap strategy.

The TFDA approval follows U.S. FDA IND clearance, establishing regulatory authorization in both jurisdictions for HCB303's planned clinical investigation.

Unlike conventional anti-TIGIT antibodies that primarily act by blocking inhibitory signaling through the TIGIT receptor, HCB303 employs a differentiated TIGIT-Fc ligand-trap strategy designed to bind multiple TIGIT-associated ligands, including PVR/CD155 and CD112, potentially limiting ligand-mediated CD226 downregulation. Combined with PD-L1 blockade and SIRPα-mediated CD47 checkpoint inhibition, HCB303 aims to coordinate innate and adaptive antitumor immunity within a single engineered molecule.

"The future of immunotherapy will not be defined simply by adding more targets, but by understanding how those targets interact," said Scott Liu, Ph.D., Founder and Chairman of HanchorBio. "HCB303 represents that philosophy. Conventional anti-TIGIT antibodies block the receptor but leave shared ligands available to engage CD226, potentially contributing to its downregulation. We therefore designed a differentiated ligand-trap strategy intended to modulate inhibitory immune signaling while potentially reducing CD226 receptor downregulation and exploring the preservation of its immune-activating function. With U.S. FDA clearance followed by Taiwan TFDA approval, we are advancing this biology into globally coordinated clinical development. This is precisely the type of differentiated therapeutic architecture our FBDB⢠platform was built to deliver."

Beyond Conventional Anti-TIGIT: Addressing the CD226 Challenge

Despite substantial interest in TIGIT-targeted cancer immunotherapy, disappointing results from several late-stage anti-TIGIT antibody trials have highlighted the pathway's complexity and the importance of maintaining activating immune signals.

TIGIT and CD226 are functionally interconnected receptors on T cells and natural killer (NK) cells. CD226 is an important activating receptor that shares ligands, including PVR/CD155 and CD112, with the inhibitory receptor TIGIT. Conventional anti-TIGIT antibodies block inhibitory TIGIT signaling but do not directly prevent shared ligands, including PVR/CD155 and CD112, from engaging CD226. However, sustained CD155 engagement can contribute to CD226 internalization and downregulation, potentially limiting immune activation.

HCB303 takes a different molecular design approach. Its TIGIT-Fc ligand-trap architecture is designed to bind shared ligands, including PVR/CD155 and CD112, with the aim of reducing ligand-mediated CD226 receptor internalization and downregulation, thereby potentially preserving CD226 cell-surface expression. However, whether preservation of receptor expression can further support CD226-mediated immune-activating signaling and translate into meaningful antitumor activity and clinical benefit remains to be established through subsequent clinical and translational studies.

HCB303 also integrates PD-L1 blockade and SIRPα-mediated CD47 checkpoint inhibition, aiming to coordinate macrophage, T-cell, and NK-cell antitumor responses within a single trispecific fusion protein.

Taiwan's Accelerated Regulatory Pathway Advances HCB303's Global Development

HCB303 received TFDA approval through Taiwan's accelerated review pathway for multinational, multicenter clinical trials. The streamlined procedure provides a 15-day review process for eligible applications, facilitating more efficient international clinical development.

TFDA has also simplified regulatory submission requirements for qualifying first-in-human studies, including removing the requirement to submit foreign participating hospitals' institutional review board approval letters under applicable conditions.

HCB303's progression from U.S. FDA IND clearance to accelerated Taiwan TFDA approval highlights HanchorBio's globally coordinated regulatory strategy, enabling more efficient advancement of differentiated immunotherapies into multinational clinical development.

From Differentiated Biology to Global Clinical Evidence

HanchorBio is preparing to advance HCB303 into its Phase 1 first-in-human, dose-escalation study (HCB303-ONC-101; NCT07859228) in patients with advanced, relapsed, or refractory solid tumors who have exhausted appropriate standard treatment options.

The study will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, biomarkers, and preliminary antitumor activity. Translational assessments will investigate target engagement, immune modulation, and exposure-response relationships to inform dose optimization and subsequent clinical development.

These translational studies will also assess biomarkers related to CD226 receptor expression, TIGIT-associated ligands, and myeloid immune cells to explore how HCB303 modulates different immune cell populations and signaling pathways, and to evaluate whether its differentiated molecular design produces the intended biological effects in patients.

"The history of TIGIT drug development reminds us that a compelling story does not automatically translate into clinical benefit," said Alvin Luk, Ph.D., M.B.A., C.C.R.A., President and Chief Medical Officer (Group) and CEO (USA) of HanchorBio. "The challenge now is to determine whether HCB303's differentiated mechanism translates into meaningful activity in patients. Our Phase 1 study goes beyond conventional dose escalation by integrating clinical pharmacology, target engagement, immune biomarkers, and early antitumor activity. We need to understand not just HCB303's safety and pharmacology, but whether we see evidence of its intended biological effects, at what exposure, and in which patients it may offer the greatest potential benefit. That evidence will determine our next clinical development decisions."

Clinical trial initiation and patient enrollment will proceed in accordance with applicable regulatory requirements, institutional ethics approval, and clinical site readiness.

FBDB⢠Platform: Expanding Differentiated Trispecific Therapeutics

HCB303 is HanchorBio's second FBDBâ¢-derived trispecific immunotherapy to advance toward human clinical evaluation, following HCB301. While HCB301 integrates SIRPα, PD-L1, and TGF-β biology, HCB303 incorporates a distinct TIGIT-Fc ligand-trap strategy alongside SIRPα and PD-L1 modulation, illustrating the platform's versatility in generating differentiated multispecific therapeutic architectures.

About HCB303

HCB303 is an investigational, humanized trispecific fusion protein developed using HanchorBio's proprietary FBDB⢠platform. It is designed to simultaneously modulate the SIRPα/CD47, PD-L1/PD-1, and TIGIT/PVR immune pathways, integrating macrophage, T-cell, and NK-cell antitumor immunity within a single engineered molecule. HCB303 is being developed as a potential treatment for advanced solid tumors. Its safety and efficacy have not been established.

About HanchorBio

HanchorBio (TWSE: 7827) is a global clinical-stage biotechnology company focused on inventing and developing next-generation biologics for cancer and immune-mediated diseases using its proprietary FBDB⢠platform.

HanchorBio's pipeline includes HCB101, its lead SIRPα-based innate immune checkpoint program; HCB301, a clinical-stage trispecific immunotherapy targeting SIRPα, PD-L1, and TGF-β biology; HCB303, a clinical-stage trispecific immunotherapy integrating SIRPα/CD47, PD-L1/PD-1, and TIGIT/PVR biology; and additional programs across oncology and immune-mediated diseases. For more information, please visit: https://www.HanchorBio.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding the clinical development of HCB303; the timing, initiation, design, conduct, and potential outcomes of future clinical studies; HCB303's proposed mechanisms, therapeutic characteristics, safety, and antitumor activity; potential preservation of CD226 expression or signaling; HanchorBio's global development strategy; and the capabilities and potential of the FBDB⢠platform. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those described. U.S. FDA clearance and Taiwan TFDA approval authorize clinical investigation in accordance with applicable requirements but do not constitute marketing approval or establish the safety or efficacy of HCB303. Mechanistic hypotheses and preclinical observations may not translate into clinical benefit. There can be no assurance regarding the timing or success of clinical development or future regulatory approvals. HanchorBio undertakes no obligation to update forward-looking statements except as required by applicable law.

HanchorBio Business Development Contact:

Email: [email protected]

SOURCE HanchorBio Inc.

Share this article

New York City and Cancun Lead Global Destination Demand as Travelers Plan Winter Getaways

NEEDHAM, Mass., Oct. 30, 2026 /PRNewswire/ -- Tripadvisor, the world's largest travel guidance platform, today released initial data from its seasonal Winter Travel Index, revealing the top trending destinations for U.S. travelers during the upcoming winter season.

Top domestic U.S. travel destinations include a mix of cities with notable holiday footprints such as New York and Las Vegas alongside warm-weather spots in Florida and Hawaii. Internationally, hot spots in Mexico, Dominican Republic and Aruba continue to capture travelers' attention as they seek to escape the cold and hit the beach during peak snow season.

The platform data also reveals how destination demand shifts across key holiday travel periods, with travelers flocking to entertainment and cultural hubs like New York City, Las Vegas, and Orlando for Thanksgiving weekend, and opting for coastal and resort getaways like Key West and Honolulu for Christmas and New Year.

"Whether American travelers are heading toward the sun, with Cancun and the Caribbean continuing to dominate, or the holiday magic of cities like New York and Las Vegas, what's clear is that they're not just booking a destination, but looking for something to do when they get there, said Aarushi Kumar, Associate Director of Research and Insights, Tripadvisor Group. "Cultural tours, day trips and outdoor adventures are leading experience bookings on Tripadvisor, while craft classes and spa days are the fastest-growing newcomers. Whatever the vacation and wherever the destination, there's something to do for every traveler."

Winter Travel Index: 2026 Top Winter Destinations

Mexico and the Caribbean continue to dominate American searches, with Cancun maintaining its reign as the #1 international winter destination. Domestically, New York City claims the top spot, with holiday happenings in the city serving as a large draw, while Florida solidifies its status as a premier winter retreat with three destinations in the top 10.

Top 5 Fastest Growing Destinations Based on YoY Growth

Year-over-year search comparisons indicate that American travelers are expanding their horizons toward historic winter wonderlands, Caribbean retreats, and holiday extensions fit for the family. Quebec City, Canada leads international acceleration as travelers embrace authentic cold-weather cultural experiences, while coastal hideaways in the Dominican Republic and British Virgin Islands see surging interest. Domestically, extended family vacation hubs in Florida and California are experiencing the highest rates of year-over-year adoption.

Holiday Travel Trends

Travel patterns indicate significant concentration around the Christmas and New Year holidays, creating distinct peak travel windows alongside high-value shoulder weeks for budget-conscious travelers.

Winter Experience Trends and Activities

Winter travelers are prioritizing curated cultural and outdoor experiences on their vacations. Cultural tours, day trips, and outdoor adventure tours lead the most-booked bookable experiences on Tripadvisor, while hands-on craft classes and wellness activities represent the fastest-growing emerging experience categories.

Top Booked Experiences:

- Cultural Tours & Historic Sights

- Options in top Domestic U.S. Destinations include:

- New York, New York

- Las Vegas, Nevada

- Key West, Florida

- Day Trips & Excursions

- Options in top Domestic U.S. Destinations include:

- Adventure & Outdoor Tours

- Options in top Domestic U.S. Destinations include:

- New York, New York

- Las Vegas, Nevada

- Key West, Florida

Top Emerging Experience Types:

- Craft Classes

- Day Spas

- Rentals

- Museums

- City Walking Tours

Methodology

Site behavioural data sourced from first-party traffic on the Tripadvisor platform for searches made by travellers in the UK between 1st August, 2026 and 31st October, 2026 for travel between 1st November 2026 and 28 February, 2027.

About Tripadvisor Inc.

Tripadvisor, the world's largest travel guidance platform*, helps millions of people each month** become better travelers, from planning to booking to taking a trip. Travelers across the globe use Tripadvisor's website and app to discover where to stay, what to do and where to eat based on guidance from those who have been there before. With more than a billion reviews and contributions, travelers turn to Tripadvisor to find deals on accommodations, book experiences, reserve tables at delicious restaurants and discover great places nearby.

Tripadvisor LLC is a wholly owned subsidiary of Tripadvisor, Inc. (Nasdaq: TRIP). The subsidiaries of Tripadvisor, Inc. own and operate a portfolio of travel media brands and businesses, operating under various websites and apps.

* Source: SimilarWeb, unique users de-duplicated monthly, September 2026

** Source: Tripadvisor internal log files

SOURCE Tripadvisor

Share this article

Move advances plans to strengthen local care and invest in Knox's future

MOUNT VERNON, Ohio and DAYTON, Ohio, Oct. 30, 2026 /PRNewswire/ -- -- Knox Community Hospital has signed a definitive agreement to join Kettering Health, a nonprofit healthcare system in western Ohio. The agreement marks a significant milestone in a process focused on strengthening and growing local access to care and investing in Knox Community Hospital's future. The two organizations signed a letter of intent in July.

"This agreement moves us closer to a future that builds on the strengths of Knox Community Hospital while giving us greater resources to grow and meet the changing needs of our community," said Bruce D. White, President and CEO, Knox Community Hospital. "Kettering Health shares our commitment to keeping care local, supporting our physicians and employees, and investing in the services and technology our patients need."

The definitive agreement is the formal contract that outlines the terms for Knox Community Hospital to join Kettering Health. The transaction is not yet final and still subject to customary closing conditions and legal and regulatory reviews. The organizations expect Knox Community Hospital to officially join Kettering Health by January 1, 2027.

The decision to move forward follows a thorough and deliberate process led by the Knox Community Hospital Board of Trustees, along with hospital and physician leadership. Throughout the process, the priority has been strengthening trusted care close to home while positioning the hospital for long-term sustainability.

"This agreement reflects what has mattered most to our board throughout this process," said Marc Odenweller, chairman, Knox Community Hospital Board of Trustees. "It supports continued high-quality care, important local services and the people who make that care possible, while giving Knox Community Hospital access to greater resources and expertise for the future. We are confident this is a strong path forward for the hospital and our community."

"We are honored by the trust Knox Community Hospital has placed in Kettering Health and grateful for the opportunity to move forward together," said Michael Gentry, CEO, Kettering Health. "We see tremendous opportunity to build on Knox Community Hospital's strengths through continued investment, expanded resources and a shared commitment to compassionate care for the people of Knox County. We look forward to the work ahead as we begin this important next chapter."

Investing in Knox's Future

- As part of the agreement, Kettering Health has committed a significant capital investment intended to upgrade facilities, equipment and technology, including the implementation of Epic, an electronic health records system.

- Under the agreement, Kettering Health remains committed to supporting workplace stability through the transition, and maintaining current Knox Community Hospital services, with a shared goal of enhancing and expanding care to meet this community's growing needs.

- To help ensure local perspectives remain, a Knox Community Hospital Advisory Board, made up of current board members, would provide input on community priorities. Knox Community Hospital will also maintain charity care and financial assistance policies consistent with those in place today.

In the coming months, the organizations will continue permitted transition planning while completing the remaining steps required to close.

For more information and updates about Knox Community Hospital's plans, visit kch.org/strong-future-local-care.

About Knox Community Hospital

Knox Community Hospital is a 99-bed, Joint Commission-accredited community hospital located in Mount Vernon, Ohio, approximately 40 miles northeast of Columbus. Members of the Knox Community Hospital medical staff represent numerous specialties, offering a wide range of excellent clinical services. Knox's dedicated staff and strong team of volunteers are committed to providing personalized, high-quality care. Knox Community Hospital's independent, not-for-profit status ensures that all remaining revenue after expenses is committed solely to improving patient services, technology, and facilities for the health of the people of Knox County and surrounding areas. 

About Kettering Health

As a faith-based, nonprofit health system, Kettering Health strives to live God's love by promoting and restoring health. Kettering Health is made up of 14 medical centers and more than 100 outpatient locations throughout western Ohio, as well as Kettering Health Medical Group â with more than 700 board-certified providers dedicated to elevating the health, healing, and hope of the community. Kettering College, a division of Kettering Health Main Campus, is a fully accredited college that specializes in health science education. For more information, visit ketteringhealth.org. 

Media Contacts

Knox Community Hospital:

Alice Hutzel, Director of Marketing, Public Relations & Development

740-393-9085

[email protected]

Kettering Health:

Claire Myree

Senior Public Relations Specialist

(937) 762-1077

[email protected]

SOURCE Kettering Health

Share this article

LAVAL, QC, Oct. 30, 2026 /PRNewswire/ -- Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) will release its financial results for its second quarter of fiscal year 2027 on Tuesday, November 24, 2026, after the close of the TSX. A conference call to discuss these results will be held on Wednesday, November 25, 2026, at 8:00 A.M. (EST), featuring Alex Miller, President and Chief Executive Officer and Filipe Da Silva, Chief Financial Officer, who will answer live questions from analysts.

Financial analysts, investors, media, and other interested parties are invited to join the webcast on November 25 at 8:00 A.M. (EST). A presentation will include slides supporting the quarterly results.

The webcast can be accessed via the " Investors/Events & presentations " section on the Corporation's website https://corpo.couche-tard.com/en/ or directly via this link https://emportal.ink/4icmWur to join the call without operator assistance.

To join the conference call by phone, please dial 1-289-819-1299 or 1-800-990-4777 (International).

Rebroadcast: A recording of the webcast will be available on the Corporation's website for 90 days.

About Alimentation Couche-Tard Inc.

Couche-Tard is a global leader in convenience and mobility, operating in 27 countries and territories, with close to 17,300 stores, of which approximately 13,200 offer road transportation fuel. With its well-known Couche-Tard and Circle K banners, it is one of the largest independent convenience store operators in the United States and it is a leader in the convenience store industry and road transportation fuel retail in Canada, Scandinavia, the Baltics, Belgium, as well as in Ireland. It also has an important presence in Luxembourg, Germany, the Netherlands, Poland, as well as in Hong Kong Special Administrative Region of the People's Republic of China. Approximately 145,000 people are employed throughout its network.

For more information on Alimentation Couche-Tard Inc., or to consult its audited annual Consolidated Financial Statements, unaudited interim condensed consolidated financial statements and Management Discussion and Analysis, please visit: https://corpo.couche-tard.com.

SOURCE Alimentation Couche-Tard inc.

Share this article

ATLANTA, Oct. 30, 2026 /PRNewswire/ -- Novelis Inc. will report its earnings for the second quarter of fiscal year 2027 on Thursday, November 5, 2026. Following the release, Steve Fisher, President and Chief Executive Officer, and Dev Ahuja, Chief Financial Officer, will discuss the results via a live conference call for investors at 7:00 a.m. EST/5:30 p.m. IST the same day. The conference call will also be webcast live via the Novelis website, with presentation materials available online at https://investors.novelis.com.

The webcast can be accessed at:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=AGNx8aT2

To participate by telephone, participants are requested to register at:

http://services.incommconferencing.com/DiamondPassRegistration/register?confirmationNumber=13762897&linkSecurityString=1f4d023aa8

Upon registering you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.

Following the meeting, the webcast will be available for replay at https://investors.novelis.com.

About Novelis

Novelis Inc. is driven by its purpose of shaping a sustainable world together. We are a global leader in the production of innovative aluminum products and solutions and the world's largest recycler of aluminum. Our ambition is to be the leading provider of low-carbon, sustainable aluminum solutions and to achieve a fully circular economy by partnering with our suppliers, as well as our customers in the aerospace, automotive, beverage can and specialties industries throughout North America, Europe, Asia and South America. Novelis had net sales of $18.4 billion in fiscal year 2026. Novelis is a subsidiary of Hindalco Industries Limited, an industry leader in aluminum and copper, and the metals flagship company of the Aditya Birla Group, a multinational conglomerate based in Mumbai. For more information, visit novelis.com.

SOURCE Novelis Inc.

Share this article

ISLETON, Calif., Oct. 30, 2026 /PRNewswire/ -- California American Water is investing approximately $1.68 million to rehabilitate the Isleton 3B Well, helping strengthen the reliability of the local water system and extend the life of critical infrastructure serving Isleton customers.

The project will restore the well's performance and help maintain the water system's capacity through proactive inspection, cleaning, treatment and testing. By rehabilitation the existing well, California American Water can extend its useful life while reducing the potential for unexpected equipment failures and costly emergency repairs.

"Investing in our existing infrastructure is an important part of providing safe, clean, reliable water service to our customers," said Charlie Wolfe, Principal Project Delivery Engineer at California American Water. "This project will help strengthen the reliability of the Isleton water system while extending the life of infrastructure that our customers rely on every day."

Work will include inspecting the well, removing pumping equipment, cleaning, treating and disinfecting the well, installing test pumping equipment and conducting performance testing before the well is returned to service.

Construction is expected to continue through the end of 2026. Work will take place at the well site along 5th street, and nearby residents may notice increased activity, occasional noise and temporary traffic impacts near the project area.

The Isleton 3B Well project is part of California American Water's Northern Division Well Rehabilitation Program, which provides periodic maintenance at selected wells to restore performance, maintain system capacity and extend the life of existing water infrastructure.

About American Water  

American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886 and celebrating 140 years in 2026, We Keep Life Flowing® by providing safe, clean, reliable and affordable drinking water and wastewater services to approximately 14 million people with regulated operations in 14 states and on 19 military installations. American Water's approximately 7,000 talented professionals leverage their significant expertise and the company's national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders.   

For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram.

About California American Water 

California American Water, a subsidiary of American Water, provides safe, clean, reliable and affordable water and wastewater services to approximately 750,000 people.   

SOURCE American Water

Share this article

How TWOPAGES Connects Craftsmanship and Service to Simplify Custom Window Treatments

NEW YORK and LOS ANGELES and OTTAWA, ON, Oct. 30, 2026 /PRNewswire/ -- For many homeowners, custom window treatments promise a perfect fit but deliver uncertainty. TWOPAGES is closing that gap by connecting vertically integrated manufacturing with professional support throughout the buying journey. Through its Behind the Curtain documentary series, TWOPAGES offers a closer look at the craftsmanship behind its custom window treatments.

Craftsmanship Behind Every Order

From fabric development, dyeing, printing and embroidery to skilled manual cutting and sewing, shaping and quality inspection, TWOPAGES manages every major production stage with care and precision. Close attention to fabric behavior, measurements, seams and finishing helps ensure consistent quality, accurate dimensions, graceful drape and lasting performance. The brand offers 50+ collections and 1,000+ fabrics, with standard drapery production taking 3â7 days*.

Beyond craftsmanship, TWOPAGES pairs its manufacturing strength with three services supporting product selection, measurement, and installation.

Through its Design Consult Service, customers receive one-on-one guidance on fabrics, colors, hardware, and products based on their space, lifestyle, and budget. Zoom Measuring Consult provides real-time guidance; the first 20 minutes are complimentary. In eligible locations, the In-Home Measurement & Installation Service offers professional measurement or installation.

By linking front-end service with back-end production, TWOPAGES reduces uncertainty throughout the custom window treatment process.

Beyond the Window Treatments

For TWOPAGES, window treatments serve a purpose beyond decoration. They shape light, privacy, and comfort at home. Through thoughtful material selection, precise craftsmanship, and comprehensive support, the brand helps homeowners achieve these benefits more easily.

"We believe light shapes a space, and a space shapes how people feel. That is why every detail mattersâfrom the way a fabric filters natural light to the precision of its construction and the support customers receive throughout the process," said Ray Chen, Founder and CEO of TWOPAGES. "Our goal is not simply to make beautiful window treatments, but to help create homes where people can slow down, feel at ease, and be more present in everyday life."

Since 2015, TWOPAGES has served over 600,000 households worldwide, a record of trust built on craftsmanship, service, and a belief that a home should give people space to slow down, reconnect, and simply be.

To explore TWOPAGES custom window treatments and get expert help with design, measuring and installation, visit twopagescurtains.com.

*Production timelines vary for other categories, including Roman shades and bamboo shades.

SOURCE TWOPAGES

Share this article